A Comprehensive Breast Cancer Survivorship Biorepository
Description
Brief Summary
This study collects blood samples as well as clinical and self-report data from stage I-III
breast cancer survivors to create a biorepository for future use. The creation of this
biorepository will allow for future research into links between individual, molecular, and
genomic signatures and cancer outcomes.
Detailed Description
PRIMARY OBJECTIVE:
I. To create an annotated biorepository with prospectively collected blood samples from
breast cancer survivors.
SECONDARY OBJECTIVES:
I. To collect comprehensive data on social determinants of health (e.g., race/ethnicity,
acculturation, socioeconomic status, and access to care), environmental exposures (based on
zip codes/geocoding), lifestyle (e.g., diet, tobacco use), clinicopathologic characteristics,
treatment history, follow-up and current disease status, survivorship-related issues.
II. To establish an efficient process for researchers to utilize the biorepository for breast
cancer and survivorship-related studies.
OUTLINE:
Patients complete surveys, undergo collection of blood samples, and review of medical records
on study.
Phase
N/AInclusion and Exclusion Criteria
- Women of all racial and ethnic groups 18 years of age or older
- Women with a diagnosis of invasive breast cancer (stages I-III) within the past 7 years
- Women who have completed active treatment for breast cancer (surgery, chemotherapy, HER2-directed therapy and radiation)
- Prior participation on clinical trials is allowed
- Current receipt of interventional clinical trial participation
- Stage IV (metastatic) cancer
- Prior history of recurrence (except recurrence following ductal carcinoma in situ)
- Inability to give informed consent
- Unable to speak English, Spanish, Chinese, or Korean
Sites
Please contact the trial administrator to learn more about where you can participate in this trial. Please use the contact form on the right side.
Powered by
SC CTSI